Related references
Note: Only part of the references are listed.Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yI)sulfones as Selective, Orally Active RORγt Inverse Agonists
James J. -W. Duan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists
Jerome Amaudrut et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of N-indanyl benzamides as potent RORγt inverse agonists
Jinlong Tian et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer
Yan Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists
Zhonghui Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
3-Substituted Quinolines as RORγt Inverse Agonists
Virginia M. Tanis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Discovery and pharmacological evaluation of indole derivatives as potent and selective ROR gamma t inverse agonist for multiple autoimmune conditions
Nadim S. Shaikh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)
Nannan Sun et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Identification of novel quinazolinedione derivatives as RORγt inverse agonist
Yoshiyuki Fukase et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disorders
Matteo Dal Pra et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds
Junya Shirai et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives
Mitsunori Kono et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Sulfoximines as potent RORc inverse agonists
Gilles Ouvry et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Identification and biological evaluation of thiazole-based inverse agonists of RORγt
Christian Gege et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
Hua Gong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Discovery and Characterization of CD12681, a Potent ROR Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis
Gilles Ouvry et al.
CHEMMEDCHEM (2018)
Discovery of carbazole carboxamides as novel RORγt inverse agonists
Yafei Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model
David A. Carcache et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
Vrajesh B. Pandya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of (&ITcis&IT-3-({(5&ITR&IT)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1&ITH&IT-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5&ITH&IT)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist
Mitsunori Kono et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
From RORγt Agonist to Two Types of RORγt Inverse Agonists
Yonghui Wang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
RORγt inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345
Christian Gege
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
RORγ antagonists and inverse agonists: a patent review
Sarah M. Bronner et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ
Roine I. Olsson et al.
CHEMMEDCHEM (2016)
Recent progress on nuclear receptor RORγ modulators
Patrick Cyr et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742
Christian Gege
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivo
Daliya Banerjee et al.
IMMUNOLOGY (2016)
Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand
Douglas J. Marcotte et al.
BMC STRUCTURAL BIOLOGY (2016)
Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes
Marta Pelay-Gimeno et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Discovery of novel pyrazole-containing benzamides as potent ROR gamma inverse agonists
Tao Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of 1-{4-[3-Fluoro-4-((3S,6R)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist
Benjamin P. Fauber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action
Olivier Rene et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (RORγ)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligand
Yuko Nishiyama et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Development of novel silicon-containing inverse agonists of retinoic acid receptor-related orphan receptors
Hirozumi Toyama et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt
Christian Gege et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Inhibiting RORγt/Th17 axis for autoimmune disorders
Fujio Isono et al.
DRUG DISCOVERY TODAY (2014)
Conformational restriction: an effective tactic in 'follow-on'-based drug discovery
Zengjun Fang et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)
Benjamin P. Fauber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
REV-ERB and ROR nuclear receptors as drug targets
Douglas J. Kojetin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Targeting Th17 cells in autoimmune diseases
Jianfei Yang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Profound Methyl Effects in Drug Discovery and a Call for New C-H Methylation Reactions
Heike Schoenherr et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells
Yutaka Kurebayashi et al.
GENES TO CELLS (2013)
Torsion Angle Preferences in Druglike Chemical Space: A Comprehensive Guide
Christin Schaerfer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Flurry of deal-making surrounds new autoimmunity target
Sarah C. P. Williams
NATURE MEDICINE (2013)
Comprehensive Peptidomimetic Libraries Targeting Protein-Protein Interactions
Landon R. Whitby et al.
ACCOUNTS OF CHEMICAL RESEARCH (2012)
Targeting Orphan Nuclear Receptors for Treatment of Metabolic Diseases and Autoimmunity
Thomas P. Burris et al.
CHEMISTRY & BIOLOGY (2012)
Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties
Paul J. Coleman et al.
CHEMMEDCHEM (2012)
Targeting IL-17and TH17 cells in chronic inflammation
Pierre Miossec et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Inhibitory effects of azole-type fungicides on interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ
Hiroyuki Kojima et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORλt Protein
Tao Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Structural Basis of Digoxin That Antagonizes RORγt Receptor Activity and Suppresses Th17 Cell Differentiation and Interleukin (IL)-17 Production
Saori Fujita-Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Biphenyl-Substituted Oxazolidinones as Cholesteryl Ester Transfer Protein Inhibitors: Modifications of the Oxazolidinone Ring Leading to the Discovery of Anacetrapib
Cameron J. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Design, Synthesis, and Validation of a β-Turn Mimetic Library Targeting Protein-Protein and Peptide-Receptor Interactions
Landon R. Whitby et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
Jun R. Huh et al.
NATURE (2011)
Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
Laura A. Solt et al.
NATURE (2011)
Deciphering the role of Th17 cells in human disease
Cailin Moira Wilke et al.
TRENDS IN IMMUNOLOGY (2011)
A second class of nuclear receptors for oxysterols: Regulation of RORα and RORγ activity by 24S-hydroxycholesterol (cerebrosterol)
Yongjun Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Update 1 of: Beta-Strand Mimetics
Wendy A. Loughlin et al.
CHEMICAL REVIEWS (2010)
The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor-α/γ Inverse Agonist
Naresh Kumar et al.
MOLECULAR PHARMACOLOGY (2010)
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
Eli A. Stahl et al.
NATURE GENETICS (2010)
Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding
Christopher D. Cox et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Using the Golden Triangle to optimize clearance and oral absorption
Ted W. Johnson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
Rajan P. Nair et al.
NATURE GENETICS (2009)
The biological functions of T helper 17 cell effector cytokines in inflammation
Wenjun Ouyang et al.
IMMUNITY (2008)
Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis
Ken A. Brameld et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage
Lawrence Steinman
NATURE MEDICINE (2007)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6
D Yen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Mimetics of the Peptide beta-Strand
Matthew P. Glenn et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2002)
Share Paper
